Replies to post #30569 on Abattis Bioceuticals Corp (ATTBF)

[ebota12]

C'mon guay....is this information from 2015? No chance BioCubes add value for Abattis. BioCell is basically Vergence.

The hype of testing was incredibly overblown. The only way this makes sense for both sides is to become an extraction leader together.

[GreenBrickRoad]

The added value is not only that Emerald is now responsible for half of the maintenance costs, but will also contribute through orders to ensure the existence of the laboratory.

Well that's true. I was a little concerned, though not necessarily anticipating, that new Abattis management was going to turn the company into a printing press of dilution to raise money for Northern Vine's development. This new arrangement with Emerald certainly doesn't safeguard us completely from O/S rising in the future, but it does bring a second set of hands to help with the heavy lifting of Northern Vine specifically as they begin building out.

And, I hate to say it, but I think the BioCube died.. :)

You could be right though. Perhaps there's some technologies or patents tucked away somewhere that might be worth something. Not expecting any goldmines though.